Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

580 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Time course of CYP3A activity during and after metamizole (dipyrone) in healthy volunteers.
Breithaupt MH, Krohmer E, Taylor L, Körner E, Hoppe-Tichy T, Burhenne J, Foerster KI, Dachtler M, Huber G, Venkatesh R, Eggenreich K, Czock D, Mikus G, Blank A, Haefeli WE. Breithaupt MH, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2023 Aug;89(8):2458-2464. doi: 10.1111/bcp.15720. Epub 2023 Apr 1. Br J Clin Pharmacol. 2023. PMID: 36946257
Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach.
Lenard A, Hermann SA, Stoll F, Burhenne J, Foerster KI, Mikus G, Meid AD, Haefeli WE, Blank A. Lenard A, et al. Among authors: haefeli we. Cardiovasc Drugs Ther. 2023 Mar 4. doi: 10.1007/s10557-023-07443-2. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 36870039
Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin.
Krohmer E, Rohr BS, Stoll F, Gümüs KS, Bergamino M, Mikus G, Sauter M, Burhenne J, Weiss J, Meid AD, Czock D, Blank A, Haefeli WE. Krohmer E, et al. Among authors: haefeli we. Cardiovasc Drugs Ther. 2023 Dec 19. doi: 10.1007/s10557-023-07538-w. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 38112932
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers.
Rohr BS, Krohmer E, Foerster KI, Burhenne J, Schulz M, Blank A, Mikus G, Haefeli WE. Rohr BS, et al. Among authors: haefeli we. Clin Pharmacokinet. 2024 Apr;63(4):469-481. doi: 10.1007/s40262-024-01350-x. Epub 2024 Feb 23. Clin Pharmacokinet. 2024. PMID: 38393578 Free PMC article. Clinical Trial.
580 results